- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Navin Fluorine reported strong Q3 FY26 results with revenue up 47% YoY to ₹892 Cr, EBITDA up 109% to ₹308 Cr, and PAT up 122% to ₹185 Cr. 9M FY26 performance already surpassed full-year FY25 revenue and PAT. Specialty Chemicals achieved its highest-ever quarterly revenue, while CDMO gained significant momentum. Key CAPEX projects like cGMP-4 Phase-1 and AHF are now commissioned, with others on track. Management highlighted a strategic focus on Advanced Materials and leveraging AHF for niche fluorinated chemistries. The company projects a confident outlook for sustained growth across all verticals, targeting ~30% annualized EBITDA margins (+/- 200 bps) through operational excellence and capability expansion.